Lin Z - Search Results

1

PDE4DIP contributes to colorectal cancer growth and chemoresistance through modulation of the NF1/RAS signaling axis.

Pan R, Dai J, Liang W, Wang H, Ye L, Ye S, Lin Z, Huang S, Xiong Y, Zhang L, Lu L, Wang O, Shen X, Liao W, Lu X. Pan R, et al. Among authors: lin z. Cell Death Dis. 2023 Jun 24;14(6):373. doi: 10.1038/s41419-023-05885-y. Cell Death Dis. 2023. PMID: 37355626 Free PMC article.

2

AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway.

Chen T, Dai X, Dai J, Ding C, Zhang Z, Lin Z, Hu J, Lu M, Wang Z, Qi Y, Zhang L, Pan R, Zhao Z, Lu L, Liao W, Lu X. Chen T, et al. Among authors: lin z. Cell Death Dis. 2020 Oct 2;11(10):822. doi: 10.1038/s41419-020-03030-7. Cell Death Dis. 2020. PMID: 33009373 Free PMC article.

3

Epigenetic induction of lipocalin 2 expression drives acquired resistance to 5-fluorouracil in colorectal cancer through integrin β3/SRC pathway.

Zhang W, Pan R, Lu M, Zhang Q, Lin Z, Qin Y, Wang Z, Gong S, Lin H, Chong S, Lu L, Liao W, Lu X. Zhang W, et al. Among authors: lin z, lin h. Oncogene. 2021 Nov;40(45):6369-6380. doi: 10.1038/s41388-021-02029-4. Epub 2021 Sep 29. Oncogene. 2021. PMID: 34588619

4

NLRC3 deficiency promotes cutaneous wound healing due to the inhibition of p53 signaling.

Qin Y, Wu K, Zhang Z, Pan R, Lin Z, Zhang W, Huang S, Dai J, Huang R, Gong S, Lin H, Chong S, Lu L, Lu X. Qin Y, et al. Among authors: lin z, lin h. Biochim Biophys Acta Mol Basis Dis. 2022 Nov 1;1868(11):166518. doi: 10.1016/j.bbadis.2022.166518. Epub 2022 Aug 10. Biochim Biophys Acta Mol Basis Dis. 2022. PMID: 35963285 Free article.

5

RUNDC3A/SNAP25/Akt signaling mediates tumor progression and chemoresistance in gastric neuroendocrine carcinoma.

Lin Z, Kwok HF. Lin Z, et al. Cell Death Dis. 2022 Oct 1;13(10):840. doi: 10.1038/s41419-022-05294-7. Cell Death Dis. 2022. PMID: 36182960 Free PMC article.

6

RSPO2 promotes progression of ovarian cancer through dual receptor-mediated FAK/Src signaling activation.

Pan R, Yu Y, Zhu H, Zhang W, Qin Y, Ye L, Dai J, Huang R, Peng X, Ye S, Lin Z, Huang S, Chong S, Lu L, Lu X. Pan R, et al. Among authors: lin z. iScience. 2022 Sep 23;25(10):105184. doi: 10.1016/j.isci.2022.105184. eCollection 2022 Oct 21. iScience. 2022. PMID: 36217544 Free PMC article.

7

AFP-HSP90 mediated MYC/MET activation promotes tumor progression in hepatocellular carcinoma and gastric cancers.

Lin Z, Pan R, Wu L, Zhu F, Fang Q, Kwok HF, Lu X. Lin Z, et al. Cancer Cell Int. 2024 Aug 12;24(1):283. doi: 10.1186/s12935-024-03455-6. Cancer Cell Int. 2024. PMID: 39135041 Free PMC article.

8

Compromised macrophages contribute to progression of MASH to hepatocellular carcinoma in FGF21KO mice.

Shi X, Zheng Q, Wang X, Guo W, Lin Z, Gao Y, Shore E, Martin RC, Lv G, Li Y. Shi X, et al. Among authors: lin z. Sci Adv. 2024 Oct 25;10(43):eado9311. doi: 10.1126/sciadv.ado9311. Epub 2024 Oct 23. Sci Adv. 2024. PMID: 39441934 Free PMC article.

9

Inhibition of bladder cancer growth with homoharringtonine by inactivating integrin α5/β1-FAK/Src axis: A novel strategy for drug application.

Wu Q, Chen P, Li J, Lin Z, Zhang Q, Kwok HF. Wu Q, et al. Among authors: lin z. Pharmacol Res. 2023 Feb;188:106654. doi: 10.1016/j.phrs.2023.106654. Epub 2023 Jan 11. Pharmacol Res. 2023. PMID: 36640858 Free article.

10

Nanoenabled intracellular zinc bursting for efficacious reversal of gefitinib resistance in lung cancer.

Li J, Assaraf YG, Zuo W, Lin Z, Leong KW, Zhao Q, Zhu L, Kwok HF. Li J, et al. Among authors: lin z. Int J Biol Sci. 2024 May 19;20(8):3028-3045. doi: 10.7150/ijbs.95929. eCollection 2024. Int J Biol Sci. 2024. PMID: 38904022 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,810 results

Search Page

Filters